Jahresbericht 2006 - Caritas-Krankenhaus St. Josef Regensburg

Wagenlehner FM, Lunz JC, Kees F, Wieland W, Naber KG
J Chemother. 2006;18(5): 485-9 (Impact Factor 2005: 1,147)
Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi.
Hafner C, van Oers JM, Vogt T, Landthaler M, Stoehr R, Blaszyk H, Hofstaedter F,
Zwarthoff EC, Hartmann A
J Clin Invest. 2006;116(8): 2201-2207 (Impact Factor 2005: 15,053)
Metanephric adenoma of the kidney: a clinico-pathological and molecular study of two
cases.
Burger M, Junker K, Denzinger S, Schubert T, Stöhr R, Wieland WF, Hartmann A J Clin
Pathol. 2006 (Impact Factor 2005: 2,170)
Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant
number of cells reside in early G1-phase.
Obermann EC, Went P, Tzankov A, Pileri SA, Hofstaedter F, Marienhagen J, Stoehr R,
Dirnhofer S
J Clin Pathol. 2006; (Impact Factor 2005: 2,170)
High Frequency of FGFR3 Mutations in Adenoid Seborrheic Keratoses.
Hafner C, van Oers JM, Hartmann A, Landthaler M, Stoehr R, Blaszyk H, Hofstaedter F,
Zwarthoff EC, Vogt T
J Invest Dermatol. 2006;126(11): 2404-7 (Impact Factor 2005: 4,406)
Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch
repair gene expression in prostate cancer.
Burger M, Denzinger S, Hammerschmied CG, Tannapfel A, Obermann EC, Wieland WF,
Hartmann A, Stoehr R
J Mol Med. 2006;84(10): 833-41 (Impact Factor 2005: 4,702)
Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and
require panurothelial treatment for tumor clearance.
Catto JW, Hartmann A, Stoehr R, Bolderson E, Rehman I, Rosario DJ, Hamdy FC, Meuth
M
J Urol. 2006;175(6): 2323-30 (Impact Factor 2005: 3,592)
Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an
age-matched random sample.
Ibach B, Binder H, Dragon M, Poljansky S, Haen E, Schmitz E, Koch H, Putzhammer A,
Kluenemann H, Wieland W, Hajak G
Neurobiol Aging. 2006;27(9): 1202-11 (Impact Factor 2005: 5,312)
Bladder exstrophy-epispadias complex: Investigation of suppressor of variegation,
enhancer of zeste and Trithorax (SET) as a candidate gene in a
large cohort of patients.
Reutter H, Thauvin-Robinet C, Boemers TM, Rösch WH, Ludwig M
Scand J Urol Nephrol. 2006;40(3): 221-4 (Impact Factor 2005: 0,677)
26